Drugmaker Urges FDA for Stricter Bioequivalence Testing on Injectable Schizophrenia Medication
2025-05-11
PubComNonGov2025-05-11
By Janelle B. Daquioag
WASHINGTON, May 11 -- Alkermes, Inc., a biopharmaceutical company headquartered in Dublin, Ireland, has formally requested the Food and Drug Administration (FDA) to revise its draft guidance on demons . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, May 11 -- Alkermes, Inc., a biopharmaceutical company headquartered in Dublin, Ireland, has formally requested the Food and Drug Administration (FDA) to revise its draft guidance on demons . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2025